BIPOLAR DISORDER II

Clinical trials for BIPOLAR DISORDER II explained in plain language.

Never miss a new study

Get alerted when new BIPOLAR DISORDER II trials appear

Sign up with your email to follow new studies for BIPOLAR DISORDER II, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 2

New drug aims to calm severe agitation in kids with mental health conditions

Symptom relief Recruiting now

This study tests an experimental drug called BXCL501 to see if it can safely reduce agitation in children and teenagers aged 10-17 who have schizophrenia or bipolar disorder. The trial involves 140 participants and measures changes in agitation using a standard rating scale. The …

Matched conditions: BIPOLAR DISORDER II

Phase: PHASE1 • Sponsor: BioXcel Therapeutics Inc • Aim: Symptom relief

Last updated May 08, 2026 12:03 UTC

BIPOLAR DISORDER II

Get alerted when new BIPOLAR DISORDER II trials appear

New drug aims to calm severe agitation in kids with mental health conditions